Biohaven Ltd.
BHVN
$8.27
-$0.10-1.20%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.61% | 30.70% | 30.17% | 26.72% | 42.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.68% | 17.07% | 31.51% | 38.78% | 63.56% |
| Operating Income | 0.68% | -17.07% | -31.51% | -38.78% | -63.56% |
| Income Before Tax | 12.81% | 3.22% | -2.10% | -71.09% | -106.49% |
| Income Tax Expenses | 96.19% | 316.95% | 122.89% | 144.21% | 153.15% |
| Earnings from Continuing Operations | 12.71% | 3.01% | -2.73% | -71.82% | -107.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.71% | 3.01% | -2.73% | -71.82% | -107.37% |
| EBIT | 0.68% | -17.07% | -31.51% | -38.78% | -63.56% |
| EBITDA | 0.98% | -16.88% | -31.56% | -38.91% | -64.37% |
| EPS Basic | 25.88% | 18.76% | 16.36% | -37.00% | -65.63% |
| Normalized Basic EPS | 11.49% | -1.57% | -4.86% | -7.35% | -29.04% |
| EPS Diluted | 25.88% | 18.76% | 16.36% | -37.00% | -65.63% |
| Normalized Diluted EPS | 11.49% | -1.57% | -4.86% | -7.35% | -29.04% |
| Average Basic Shares Outstanding | 17.96% | 19.65% | 25.86% | 29.20% | 28.13% |
| Average Diluted Shares Outstanding | 17.96% | 19.65% | 25.86% | 29.20% | 28.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |